EDITORIAL
Published on 07 May 2021
Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?
doi 10.3389/fmed.2021.673991
- 1,531 views
- 1 citation
- Frontiers in Medicine
- Gastroenterology
- Research Topics
- Personalizing Treatment In IBD: Hype or Reality In 2020?
Personalizing Treatment In IBD: Hype or Reality In 2020?
21k
Total downloads
109k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 28 Jan 2021
How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data
doi 10.3389/fmed.2021.640813
- 12,788 views
- 22 citations
MINI REVIEW
Published on 17 Dec 2020
Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
doi 10.3389/fmed.2020.580803
- 4,542 views
- 31 citations
SYSTEMATIC REVIEW
Published on 27 Nov 2020
Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
doi 10.3389/fmed.2020.606298
- 12,885 views
- 78 citations
REVIEW
Published on 02 Sep 2020
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
doi 10.3389/fmed.2020.00517
- 15,357 views
- 93 citations
REVIEW
Published on 02 Apr 2020
Predicting Response to Vedolizumab in Inflammatory Bowel Disease
doi 10.3389/fmed.2020.00076
- 7,018 views
- 13 citations
REVIEW
Published on 29 Jan 2020
A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis
doi 10.3389/fmed.2019.00337
- 13,956 views
- 22 citations
REVIEW
Published on 17 Jan 2020
Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research
doi 10.3389/fmed.2019.00334
- 24,730 views
- 50 citations
REVIEW
Published on 08 Jan 2020
Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease
doi 10.3389/fmed.2019.00302
- 4,514 views
- 12 citations
MINI REVIEW
Published on 28 Nov 2019
Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
doi 10.3389/fmed.2019.00279
- 5,595 views
- 17 citations
ORIGINAL RESEARCH
Published on 01 Nov 2019
Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease
doi 10.3389/fmed.2019.00234
- 3,460 views
- 6 citations
Published in
Frontiers in Medicine
- Gastroenterology
Impact
- 109kTopic views
- 85kArticle views
- 21kArticle downloads